Dr. Ahmad Daher, MD
Claim this profileHartford Hospital
Area of expertise
Glioblastoma
Ahmad Daher, MD has run 3 trials for Glioblastoma. Some of their research focus areas include:
Brain Tumor
Ahmad Daher, MD has run 2 trials for Brain Tumor. Some of their research focus areas include:
Affiliated Hospitals
Hartford Hospital
University Of Illinois
Clinical Trials Ahmad Daher, MD is currently running
Lomustine + Standard Therapy
for Glioblastoma
This phase III trial compares the effect of adding lomustine to standard chemotherapy with temozolomide and radiation therapy versus temozolomide and radiation therapy alone in shrinking or stabilizing newly diagnosed MGMT methylated glioblastoma. MGMT methylated tumors are more likely to respond to temozolomide chemotherapy. Temozolomide is in a class of medications called alkylating agents. It works by damaging the cell's DNA and may kill tumor cells and slow down or stop tumor growth. Lomustine is a chemotherapy drug and in a class of medications called alkylating agents. It damages the cell's DNA and may kill tumor cells. Radiation therapy uses high energy x-ray photons to kill tumor cells and shrink tumors. Adding lomustine to standard chemotherapy with temozolomide and radiation therapy may shrink or stabilize glioblastoma.
Recruiting
2 awards
Phase 3
4 criteria
Radiation Therapy vs Observation
for Meningioma
This trial studies if radiation therapy helps prevent the return of grade II meningioma after surgery. Radiation therapy uses powerful x-rays to destroy any leftover cancer cells. The goal is to see if this improves patient outcomes compared to just monitoring them. Radiation therapy has shown success in stabilizing tumor growth and reducing recurrence risk.
Recruiting
2 awards
Phase 3
12 criteria
More about Ahmad Daher, MD
Clinical Trial Related
3 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Ahmad Daher, MD has experience with
- Radiation Therapy
- Nivolumab
- Lomustine
- Abemaciclib
- Clinical Observation
- Ipilimumab
Breakdown of trials Ahmad Daher, MD has run
Glioblastoma
Gliosarcoma
Protoplasmic Astrocytoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ahmad Daher, MD specialize in?
Ahmad Daher, MD focuses on Glioblastoma and Brain Tumor. In particular, much of their work with Glioblastoma has involved IDH negative patients, or patients who are MET positive.
Is Ahmad Daher, MD currently recruiting for clinical trials?
Yes, Ahmad Daher, MD is currently recruiting for 3 clinical trials in Hartford Connecticut. If you're interested in participating, you should apply.
Are there any treatments that Ahmad Daher, MD has studied deeply?
Yes, Ahmad Daher, MD has studied treatments such as Radiation Therapy, Nivolumab, Lomustine.
What is the best way to schedule an appointment with Ahmad Daher, MD?
Apply for one of the trials that Ahmad Daher, MD is conducting.
What is the office address of Ahmad Daher, MD?
The office of Ahmad Daher, MD is located at: Hartford Hospital, Hartford, Connecticut 06102 United States. This is the address for their practice at the Hartford Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.